This is a drug-target Mendelian randomization study using individual and summary data, which relies on three instrumental variable assumptions. First to satisfy relevance, genetic variants within the protein-encoding genes (HMGCR, PCSK9, and NPC1L1) and associated with LDL-C were used to proxy the use of statins, PCSK9 inhibitors, and ezetimibe respectively. Second, the use of genetic variants not associated with confounders of exposure-outcome association addresses independence.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Yap
Contact Yap, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack